Neovasc Inc., a prominent player in the medical device industry, is headquartered in Canada and operates primarily in North America and Europe. Founded in 2014, the company has quickly established itself as a leader in innovative solutions for cardiovascular diseases, focusing on the development of advanced products for the treatment of refractory angina and other vascular conditions. Neovasc's flagship products, including the Tiara™ transcatheter mitral valve and the Neovasc Reducer™, are designed to address unmet clinical needs with unique, minimally invasive technologies. These offerings have positioned Neovasc as a key innovator in the cardiovascular space, earning recognition for their potential to improve patient outcomes. With a commitment to advancing healthcare, Neovasc Inc. continues to make significant strides in the medical device sector.
We don't have data for Neovasc Inc., but we can show you information about their parent organization instead.
View parent company